Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Location » New Zealand

Wellington, New Zealand Clinical Trials

Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Anemia

CTI Investigative Site 64004 Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Arthritis and Arthritic Pain

Research Site

A clinical research study of IPI-145 and Placebo for the treatment of Rheumatoid Arthritis

Research Site Updated

A clinical research study for the treatment of Arthritis, Rheumatoid

1301.1.3407 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

Investigational Site Number 554006 Updated

A clinical trial to evaluate treatments using sarilumab SAR153191 (REGN88) and placebo for patients with Rheumatoid Arthritis

Asthma

Research Site Updated

A clinical research study of lebrikizumab and placebo for the treatment of Asthma

Atrial Fibrillation

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Bronchiectasis

Research Site

A clinical trial seeking patients for a research study for the treatment of Bronchiectasis

Constipation

Research Site

Patients are needed to participate in a clinical research study of Placebo and Linaclotide to evaluate Irritable Bowel Syndrome With Constipation (IBS-C)

COPD (Chronic Obstructive Pulmonary Disease)

P3 Research

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

Diabetes Mellitus, Type 1

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study of MK-1293, Lantus™ and Prandial Insulin for the treatment of Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 2

Research Site

A clinical research study of Placebo, Canagliflozin, 100 mg and Canagliflozin, 300 mg for the treatment of Diabetes Mellitus, Type 2 or Albuminuria

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study of MK-1293 and Lantus™ to evaluate Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study for the treatment of Type 2 Diabetes Mellitus

View More »

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-3102 and Placebo for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 2

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

Endometriosis

Site Reference ID/Investigator# 96060

A Phase 3 clinical study for patients with Endometriosis

Heart Failure

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical research study of MK-7145 2 mg, MK-7145 8 mg, Furosemide and Torsemide for the treatment of Renal Impairment or Heart Failure

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Hepatitis

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study evaluating MK-5172 for the treatment of Hepatitis C

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study of MK-8408 to evaluate Hepatitis C Infection

Inflammatory Bowel Disease

Aotea Pathology (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

P3 Research Limited

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Malignant Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Multiple Myeloma

Wellington Hospital

A Phase 3 clinical study for patients with Multiple Myeloma

Wellington Regional Hospital

A clinical trial to evaluate treatments using MLN9708 + Lenalidomide + Dexamethasone and Placebo + Lenalidomide + Dexamethasone for patients with Relapsed Multiple Myeloma or Refractory Multiple Myeloma

Myelofibrosis

CTI Investigative Site 64004 Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Neoplasms

Research Site Updated

A clinical research study of Trabectedin, DOXIL and Dexamethasone for the treatment of Ovarian Neoplasms, Peritoneal Neoplasms or Fallopian Tube Neoplasms

Rheumatoid Arthritis

Research Site Updated

A clinical research study for the treatment of Arthritis, Rheumatoid

Research Site

A clinical research study of IPI-145 and Placebo for the treatment of Rheumatoid Arthritis

1301.1.3407 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

Investigational Site Number 554006 Updated

A clinical trial to evaluate treatments using sarilumab SAR153191 (REGN88) and placebo for patients with Rheumatoid Arthritis

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Ulcerative Colitis

Aotea Pathology (Local Lab)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Aotea Pathology (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Aotea Pathology (Local Lab)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

View More »

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

P3 Research Limited

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Ulcers

Aotea Pathology (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Aotea Pathology (Local Lab)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Aotea Pathology (Local Lab)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Bowen Hospital

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

View More »

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

P3 Research Limited

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Vascular Diseases

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus